Acute renal failure after intravitreal antivascular endothelial growth factor therapy

Acute renal failure after intravitreal antivascular endothelial growth factor therapy

Bibliographic Details
Main Authors:	Yu-Fang Huang, Shih-Jen Chen, Min-Yen Hsu, De-Kuang Hwang
Format:	Article
Language:	English
Published:	Elsevier 2017-06-01
Series:	Journal of the Formosan Medical Association
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664616302522

Similar Items

Intravitreal antivascular endothelial growth factors for retinopathy of prematurity in Ibadan: Method of administration
by: Yewande Olubunmi Babalola, et al.
Published: (2020-01-01)

Evaluation of the effect of intravitreal antivascular endothelial growth factor versus medical treatment in acute central serous chorioretinopathy
by: Moataz A Sallam
Published: (2022-01-01)

Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs
by: Haitao Zhang, et al.
Published: (2022-01-01)

A Clear Cell Renal Cell Carcinoma Inhibiting the Response to Intravitreal Antivascular Endothelial Growth Factor Therapy in Wet Age-Related Macular Disease
by: Manuel S. Falcão, et al.
Published: (2012-12-01)

Association between the response of intravitreal antivascular endothelial growth factor injection and systemic factors of diabetic macular edema
by: So Hyung Lee, et al.
Published: (2024-04-01)

Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
by: Yu-Yen Chen, et al.
Published: (2019-12-01)

The efficacy of intravitreal antivascular endothelial growth factor as primary treatment of retinopathy of prematurity: Experience from a tertiary hospital
by: H Kana, et al.
Published: (2017-03-01)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
by: Ajay Indur Dudani, et al.
Published: (2019-01-01)

Real-world outcomes of intravitreal antivascular endothelial growth factors for neovascular age-related macular degeneration in Taiwan: A 4-year longitudinal study
by: Benjamin Chi-Lan Yang, et al.
Published: (2019-01-01)

Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration
by: Tranos P, et al.
Published: (2013-06-01)

Promising novel treatment against keloids: Antivascular endothelial growth factor agents
by: Bahareh Abtahi-Naeini, et al.
Published: (2019-01-01)

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
by: Asahi MG, et al.
Published: (2017-11-01)

Efficacy and safety profile of intravitreal dexamethasone implant versus antivascular endothelial growth factor treatment in diabetic macular edema: a systematic review and meta-analysis
by: Sheng-Chu Chi, et al.
Published: (2023-05-01)

Risk of Thromboembolic Events and Major Adverse Cardiovascular Events Following Antivascular Endothelial Growth Factor Therapy in Patients with Colorectal Cancer
by: Yen-Cheng Chen, et al.
Published: (2022-12-01)

Antivascular endothelial growth factor in treatment of choroidal osteoma not associated with choroidal neovascular membrane
by: Thomas Cherian, et al.
Published: (2017-01-01)

Nanomaterial-Based Antivascular Therapy in the Multimodal Treatment of Cancer
by: Xiaocong Ma, et al.
Published: (2023-04-01)

Bypass of Tumor Drug Resistance by Antivascular Therapy
by: Dina Preise, et al.
Published: (2003-11-01)

Commentary: Ziv-aflibercept: An alternative antivascular endothelial growth factor agent for polypoidal choroidal vasculopathy
by: Kumar Anshuman, et al.
Published: (2019-01-01)

Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
by: In Hwan Hong, et al.
Published: (2017-01-01)

Combined argon laser photocoagulation and antivascular endothelial growth factor for management of macular polypoidal choroidal vasculopathy
by: Parveen Sen, et al.
Published: (2016-01-01)

Changes in the Systemic Expression of Sirtuin-1 and Oxidative Stress after Intravitreal Anti-Vascular Endothelial Growth Factor in Patients with Retinal Vein Occlusion
by: De-Kuang Hwang, et al.
Published: (2020-10-01)

Systematic review with network meta-analysis of antivascular endothelial growth factor use in managing polypoidal choroidal vasculopathy
by: Sheng-Chu Chi, et al.
Published: (2021-02-01)

Antivascular endothelial growth factor for macular oedema secondary to retinal vein occlusion: a systematic review and meta-analysis
by: Chao Zhang, et al.
Published: (2022-10-01)

Fruquintinib: a novel antivascular endothelial growth factor receptor tyrosine kinase inhibitor for the treatment of metastatic colorectal cancer
by: Zhang Y, et al.
Published: (2019-08-01)

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
by: Tzu-Yi Lin, et al.
Published: (2023-02-01)

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
by: Abraham Hang, et al.
Published: (2023-08-01)

Ten-year real-world outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration using pro re nata regimen
by: Anja Tuulonen, et al.
Published: (2023-12-01)

Comparison of antivascular endothelial growth factor treatment for myopia choroidal neovascularisation: a systematic review and meta-analysis of randomised controlled trials
by: Chao Zhang, et al.
Published: (2023-07-01)

Full-thickness macular hole formation following antivascular endothelial growth factor injection in a case of hemicentral retinal vein occlusion
by: Srijita Mitra, et al.
Published: (2021-01-01)

The Association of Intravitreal Injections of Different Anti-Vascular Endothelial Growth Factor with Systemic Outcomes in Diabetic Patients
by: Eugene Yu-Chuan Kang, et al.
Published: (2023-03-01)

Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context
by: Charles C Wykoff, et al.
Published: (2022-08-01)

Use of Arsenic Trioxide as an Antivascular and Thermosensitizing Agent in Solid Tumors
by: Robert J. Griffin, et al.
Published: (2000-01-01)

Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids
by: Inès Ben Ghezala, et al.
Published: (2022-08-01)

Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments
by: Shirakata Y, et al.
Published: (2016-02-01)

Thrombotic Microangiopathy and Acute Kidney Injury Induced After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors VEGF Blockade-Related TMA After Intravitreal Use
by: Ramy M. Hanna, et al.
Published: (2020-10-01)

Zinc-Substituted Pheophorbide A Is a Safe and Efficient Antivascular Photodynamic Agent
by: Milena J. Szafraniec, et al.
Published: (2022-02-01)

Effect of intravitreal injection of anti-vascular endothelial growth factor agents on systemic concentration of vascular endothelial growth factor
by: Mei Wang, et al.
Published: (2023-04-01)

Comparison of intravitreal ganciclovir monotherapy and combination with foscarnet as initial therapy for cytomegalovirus retinitis
by: Jing-Jing Fan, et al.
Published: (2018-10-01)

Bilateral same-session intravitreal injections of anti-vascular endothelial growth factors
by: Nakhleh E. Abu-Yaghi, et al.
Published: (2014-12-01)

Massive Inguinoscrotal Hernia Associated with Acute Renal Failure Complicated Acute Pyelonephritis
by: Ching-Chieh Lin, et al.
Published: (2015-01-01)